Lab Notes: Trevena advances new pain drug; Ocugen receives good news from FDA
December 17, 2021 at 12:17 PM EST
Philadelphia-area life sciences news this week includes updates on a potential new pain medicine, a gene therapy candidate, and a key patent.
